Citigroup Maintains Neutral on Lear, Raises Price Target to $138

Citigroup analyst Itay Michaeli maintains Lear (NYSE:LEA) with a Neutral and raises the price target from $137 to $138.

Citigroup analyst Itay Michaeli maintains Lear (NYSE:LEA) with a Neutral and raises the price target from $137 to $138.

Total
0
Shares
Related Posts
Read More

Palatin Provides Corporate Update And Highlights Strategic Priorities For Calendar Year 2024; Completed Asset Sale To Cosette Pharmaceuticals For Up To $171M; $12M Upfront Plus Sales-Based Milestones Of Up To $159M

Dry Eye Disease (DED): PL9643 MELODY-1 Phase 3 StudyData Base Lock 2H January 2024Topline Data Readout Expected Early 1Q Calendar Year 2024Ulcerative Colitis (UC): Oral PL8177 Phase 2 Clinical Study in Active UC

PTN